Gamma Delta (γδ) T Cells and Their Involvement in Behçet's Disease.

Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease. Lancet (1990) 19.57

Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol (2006) 12.29

Six-of-the-best: unique contributions of γδ T cells to immunology. Nat Rev Immunol (2013) 3.77

Gammadelta T cells: functional plasticity and heterogeneity. Nat Rev Immunol (2002) 3.64

Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Curr Opin Rheumatol (2005) 2.48

Nonpeptide ligands for human gamma delta T cells. Proc Natl Acad Sci U S A (1994) 2.33

The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol (2013) 2.19

Role of gamma delta T cells in pathogenesis and diagnosis of Behcet's disease. Lancet (1996) 2.12

Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1. Nat Genet (2013) 1.93

Gammadelta intraepithelial lymphocytes are essential mediators of host-microbial homeostasis at the intestinal mucosal surface. Proc Natl Acad Sci U S A (2011) 1.80

Detection of RNA complementary to herpes-simplex virus in mononuclear cells from patients with Behçet's syndrome and recurrent oral ulcers. Lancet (1982) 1.73

Expansion of gammadelta T-cells in Behçet's disease: role of disease activity and microbial flora in oral ulcers. J Lab Clin Med (2003) 1.69

New insights into the pathogenesis of Behçet's disease. Autoimmun Rev (2011) 1.60

Vgamma9/Vdelta2 T lymphocytes reduce the viability of intracellular Mycobacterium tuberculosis. Eur J Immunol (2000) 1.57

Behçet's disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy (2005) 1.53

Human neutrophil clearance of bacterial pathogens triggers anti-microbial γδ T cell responses in early infection. PLoS Pathog (2011) 1.46

Association between the 65-kilodalton heat shock protein, Streptococcus sanguis, and the corresponding antibodies in Behçet's syndrome. Infect Immun (1991) 1.45

Behçet's disease. Best Pract Res Clin Rheumatol (2004) 1.41

Autoimmunity vs autoinflammation in Behcet's disease: do we oversimplify a complex disorder? Rheumatology (Oxford) (2006) 1.35

Flexible migration program regulates gamma delta T-cell involvement in humoral immunity. Blood (2003) 1.32

FcgammaRIII discriminates between 2 subsets of Vgamma9Vdelta2 effector cells with different responses and activation pathways. Blood (2004) 1.27

Role of gammadelta T lymphocytes in the development of Behçet's disease. Clin Exp Immunol (1997) 1.26

Behçet's disease--a contemporary review. J Autoimmun (2009) 1.25

CXCR5 identifies a subset of Vgamma9Vdelta2 T cells which secrete IL-4 and IL-10 and help B cells for antibody production. J Immunol (2006) 1.19

Behçet's disease: ocular effects and treatment. Prog Retin Eye Res (2007) 1.17

Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease. Clin Exp Immunol (2004) 1.16

Expression of Th-17 and RORγt mRNA in Behçet's Disease. Med Sci Monit (2011) 1.13

Understanding the complexity of γδ T-cell subsets in mouse and human. Immunology (2012) 1.12

Increased peripheral blood gamma delta+ T cells and natural killer cells in Behçet's disease. J Rheumatol (1992) 1.10

Sex-specific phenotypical and functional differences in peripheral human Vgamma9/Vdelta2 T cells. J Leukoc Biol (2006) 1.08

Behçet's disease. Arthritis Res Ther (2003) 1.07

HSP 60 expression in mucocutaneous lesions of Behçet's disease. J Am Acad Dermatol (2001) 1.05

Vgamma9Vdelta2 T cells recovered from eyes of patients with Behçet's disease recognize non-peptide prenyl pyrophosphate antigens. J Neuroimmunol (2002) 1.05

The expression of gamma delta T cell receptor and the prevalence of primed, activated and IgA-bound T cells in Behçet's syndrome. Clin Exp Immunol (1990) 1.04

Phenotype and functional profile of T cells expressing gamma delta receptor from patients with active Behçet's disease. J Rheumatol (1994) 1.04

Gammadelta T cells in Behçet's disease (BD) and recurrent aphthous stomatitis (RAS). Clin Exp Immunol (1999) 1.00

The role of streptococcal hypersensitivity in the pathogenesis of Behçet's Disease. Eur J Dermatol (2008) 0.99

Neutrophil activation in Behçet's disease. Clin Exp Rheumatol (2001) 0.97

Roles of γδ T cells in the pathogenesis of autoimmune diseases. Clin Dev Immunol (2013) 0.96

Function and specificity of human gamma/delta-positive T cells. Crit Rev Immunol (1992) 0.92

Azathioprine therapy selectively ablates human Vδ2⁺ T cells in Crohn's disease. J Clin Invest (2015) 0.91

Role of gamma-delta (γδ) T cells in autoimmunity. J Leukoc Biol (2014) 0.87

Vgamma9/Vdelta2 T lymphocytes in Italian patients with Behçet's disease: evidence for expansion, and tumour necrosis factor receptor II and interleukin-12 receptor beta1 expression in active disease. Arthritis Res Ther (2003) 0.86

Detection of HSV-1 DNA in patients with Behçet's syndrome and in patients with recurrent oral ulcers by the polymerase chain reaction. J Med Microbiol (1991) 0.85

Preferential activation of circulating CD8+ and gammadelta T cells in patients with active Behçet's disease and HLA-B51. Clin Exp Rheumatol (2008) 0.84

Proinflammatory Vδ2+ T cells populate the human intestinal mucosa and enhance IFN-γ production by colonic αβ T cells. J Immunol (2013) 0.83

Phenotype and functional changes of Vgamma9/Vdelta2 T lymphocytes in Behçet's disease and the effect of infliximab on Vgamma9/Vdelta2 T cell expansion, activation and cytotoxicity. Arthritis Res Ther (2010) 0.82

Higher expression of Toll-like receptors 2, 3, 4, and 8 in ocular Behcet's disease. Invest Ophthalmol Vis Sci (2013) 0.82

Insights into the Relationship between Toll Like Receptors and Gamma Delta T Cell Responses. Front Immunol (2014) 0.82

The role of TLR2 and 4 in Behçet's disease pathogenesis. Innate Immun (2013) 0.81

Diversity of gammadelta T cells in patients with Behcet's disease is indicative of polyclonal activation. Oral Dis (2006) 0.80

[Epidemiology of Behçet's disease]. Rev Med Interne (2014) 0.79

Pentoxifylline inhibits Vgamma9/Vdelta2 T lymphocyte activation of patients with active Behçets disease in vitro. Int J Immunopathol Pharmacol (2007) 0.79

Phenotype markers and cytokine intracellular production by CD8+ gammadelta T lymphocytes do not support a regulatory T profile in Behçet's disease patients and healthy controls. Immunol Lett (2010) 0.79

Expression of regulatory receptors on γδ T cells and their cytokine production in Behcet's disease. Arthritis Res Ther (2013) 0.78

Possible mechanisms of neutrophil activation in Behçet's disease. Int Immunopharmacol (2013) 0.78

Differential expression of suppressor of cytokine signalling proteins in Behçet's disease. Scand J Immunol (2014) 0.76

[Behaviour of gamma delta TCR+ T cells during the course of nontuberculous mycobacterial infections and proliferative response of host lymphocytes to 65kD heat shock protein]. Kekkaku (1993) 0.76

T-gammadelta receptor restriction in peripheral lymphocytes of patients with Behçet's disease. Adv Exp Med Biol (2003) 0.76